Christopher J. Ryerson

30.3k citations

201 papers · 8.5k indexed · 5 hit papers · h-index 46

Impact in

Pulmonary and Respiratory Medicine top 0.1%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Medical Imaging and Pathology Studies
- Occupational and environmental lung diseases
- Pulmonary Hypertension Research and Treatments
- Respiratory and Cough-Related Research
Physiology top 0.5%
- Sarcoidosis and Beryllium Toxicity Research

Papers in

Pulmonary and Respiratory Medicine 181
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 160
- Chronic Obstructive Pulmonary Disease (COPD) Research 58
- Medical Imaging and Pathology Studies 33
- Pulmonary Hypertension Research and Treatments 22
- Occupational and environmental lung diseases 20
- Respiratory and Cough-Related Research 18
Physiology 56
- Sarcoidosis and Beryllium Toxicity Research 48

Co-authors: Harold R. Collard Joyce Lee Kirk D. Jones Brett M. Elicker Talmadge E. King Brett Ley Jay H. Ryu Sabina A. Guler
Journals: CHEST Journal (16 papers)American Journal of Respiratory and Critical Care Medicine (15 papers)European Respiratory Journal (14 papers)Annals of the American Thoracic Society (14 papers)Respirology (10 papers)
Partner nations: Canada United States Australia

In The Last Decade

Christopher J. Ryerson

185 papers receiving 8.4k citations

Hit Papers

5 papers align trajectories log scale

Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis 2023 · 85 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 European Respiratory Review
2020 Pharmacology & Therapeutics
2017 The Lancet Respiratory Medicine
2013 CHEST Journal
2012 Annals of Internal Medicine

Peers

Countries citing papers authored by Christopher J. Ryerson

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Ryerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Ryerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Ryerson more than expected).

Fields of papers citing papers by Christopher J. Ryerson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Ryerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Ryerson. The network helps show where Christopher J. Ryerson may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher J. Ryerson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher J. Ryerson Line = papers co-authored together Christopher J. Ryerson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Application of the 2022 American Thoracic/European Respiratory Society/Japanese Respiratory Society/Associatión Latinoamericana de Tórax (ATS/ERS/JRS/ALAT) idiopathic pulmonary fibrosis and progressive pulmonary fibrosis clinical practice guideline to a Canadian population: An opinion piece Canadian Journal of Respiratory Critical Care and Sleep Medicine ·G Panaitov, Julie Morisset, Christopher J. Ryerson	2024	0
2	Characteristics of pulse oximetry and arterial blood gas in patients with fibrotic interstitial lung disease BMJ Open Respiratory Research ·M Donaldson, Archibald Fraser, Deborah Assayag, M Falahaty Naghibi, Jolene H. Fisher, Kerri A. Johannson, Martin Kolb, L. Lambrecht, H. Manganas, Veronica Marcoux, Lusi Rahmadhani Efendi, Julie Morisset, Alejandro Vázquez del Mercado, Christopher J. Ryerson	2024	0
3	The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions American Journal of Respiratory and Critical Care Medicine ·Jürgen Behr, Margaret L. Salisbury, Simon Walsh, Anna J. Podolanczuk, Lida P. Hariri, Gary M. Hunninghake, Martin Kolb, Christopher J. Ryerson, Vincent Cottin, Mary Beth Beasley, Tamera J. Corte, Allan R. Glanville, Ayodeji Adegunsoye, Cory M. Hogaboam, Wim Wuyts, Imre Noth, Justin M. Oldham, Luca Richeldi, Ganesh Raghu, Athol U. Wells	2024	11
4	Treatable traits: a comprehensive precision medicine approach in interstitial lung disease European Respiratory Journal ·Yet H. Khor, Vincent Cottin, Anne E. Holland, Yoshikazu Inoue, Vanessa M. McDonald, Justin M. Oldham, Elisabetta Renzoni, Anne‐Marie Russell, Mary E. Strek, Christopher J. Ryerson	2023	14
5	Creating a provincial post COVID‐19 interdisciplinary clinical care network as a learning health system during the pandemic: Integrating clinical care and research Learning Health Systems ·Adeera Levin, 謙一郎北山, Alison M. Hoens, Christopher Carlsten, Christopher J. Ryerson, YangHo Jin, Stirling Bryan, J. Stremmler, Tamsin Tarling, Ж. З. Фарманов, Danielle C. Lavallee	2022	16
6	Clinical relevance of rheumatoid factor and anti‐citrullinated peptides in fibrotic interstitial lung disease Respirology ·Boyang Zheng, Archibald Fraser, Nathan Hambly, Kerri A. Johannson, Deborah Assayag, Jolene H. Fisher, H. Manganas, Veronica Marcoux, Nasreen Khalil, Martin Kolb, Christopher J. Ryerson, (unknown)	2022	2
7	Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement American Journal of Respiratory and Critical Care Medicine ·Siti Iriana Ridzwan, Sonye K. Danoff, Anne‐Marie Russell, Christopher J. Ryerson, Atsushi Suzuki, Marlies Wijsenbeek, Sabrina Bajwah, Pauline Bianchi, Tamera J. Corte, Joyce Lee, Kathleen O. Lindell, Toby M. Maher, Fernando J. Martínez, Paula Meek, Ganesh Raghu, Cândida Nathaly Cordeiro Souto, Sandra Medina Ibarra, Monika M. Safford, Jamie Sheth, Jeffrey J. Swigris	2021	54
8	Social Media Content of Idiopathic Pulmonary Fibrosis Groups and Pages on Facebook: Cross-sectional Analysis JMIR Public Health and Surveillance ·雅久深野, M. I. Gordeeva, Sabina A. Guler, Kerri A. Johannson, Christopher J. Ryerson, G.C. Goobie	2021	8
9	Treatment Initiation in Patients with Interstitial Lung Disease in Canada Annals of the American Thoracic Society ·Deborah Assayag, Yvonne Hanáková, Kerri A. Johannson, Charlene D. Fell, Martin Kolb, Gerard Cox, Nathan Hambly, H. Manganas, Julie Morisset, Jolene H. Fisher, Shane Shapera, Andrea S. Gershon, Teresa To, Mohsen Sadatsafavi, Pearce Wilcox, Andrew J. Halayko, Nasreen Khalil, Christopher J. Ryerson	2021	7
10	Prevalence and prognostic impact of physical frailty in interstitial lung disease: A prospective cohort study Respirology ·Mohammed A. Farooqi, Sachi O’Hoski, Sarah Goodwin, Alexander N. Rozmyslov, Zhiyan Guo, Gerard Cox, Joshua Wald, Christopher J. Ryerson, Marla Beauchamp, Nathan Hambly, Martin Kolb	2021	17
11	Canadian Thoracic Society position statement on rehabilitation for COVID-19 and implications for pulmonary rehabilitation Canadian Journal of Respiratory Critical Care and Sleep Medicine ·Marla Beauchamp, Tania Janaudis‐Ferreira, Joshua Wald, 冰龚, Mohit Bhutani, Jean Bourbeau, Dina Brooks, Gail Dechman, Roger Goldstein, Donna Goodridge, Paul Hernandez, Darcy D. Marciniuk, Erika Penz, Christopher J. Ryerson, Didier Saey, Michael K. Stickland, Jason Weatherald	2021	11
12	Changes in pulmonary function and patient-reported outcomes during COVID-19 recovery: a longitudinal, prospective cohort study ERJ Open Research ·Aditi Shah, Min Hyung Ryu, Cameron Hague, Darra Murphy, James C. Johnston, Christopher J. Ryerson, Christopher Carlsten, Alyson W. Wong	2021	20
13	Air Pollution and Interstitial Lung Diseases: Defining Epigenomic Effects American Journal of Respiratory and Critical Care Medicine ·G.C. Goobie, Mehdi Nouraie, Yingze Zhang, Daniel J. Kass, Christopher J. Ryerson, Christopher Carlsten, Kerri A. Johannson	2020	22
14	Long-term monitoring of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society Position Statement Canadian Journal of Respiratory Critical Care and Sleep Medicine ·Jolene H. Fisher, Kerri A. Johannson, Deborah Assayag, Julie Morisset, Shatha Alkhayyal, H. Manganas, Shane Shapera, Charlene D. Fell, Christopher J. Ryerson, Martin Kolb	2020	10
15	Costs of Workplace Productivity Loss in Patients with Connective Tissue Disease–associated Interstitial Lung Disease Annals of the American Thoracic Society ·Yang Liu, Mohsen Sadatsafavi, Jolene H. Fisher, Julie Morisset, Kerri A. Johannson, Charlene D. Fell, Martin Kolb, H. Manganas, Xinzhe Xia, Andrea S. Gershon, Andrew J. Halayko, Nathan Hambly, Nasreen Khalil, Shane Shapera, Teresa To, Pearce Wilcox, Sabina A. Guler, Christopher J. Ryerson	2020	5
16	Oesophageal diameter is associated with severity but not progression of systemic sclerosis‐associated interstitial lung disease Respirology ·Tiffany A. Winstone, Cameron Hague, Jeanette Soon, Bilan Yi, Darra Murphy, Jonathon Leipsic, James V. Dunne, Pearce Wilcox, Christopher J. Ryerson	2018	15
17	Cough is less common and less severe in systemic sclerosis‐associated interstitial lung disease compared to other fibrotic interstitial lung diseases Respirology ·N.A. Anon, Pearce Wilcox, Ian Glaspole, Tamera J. Corte, Darra Murphy, Cameron Hague, Christopher J. Ryerson	2017	31
18	Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD Respirology ·K. V. Sripathy, J. Ruangsri, Clara Maria de Araújo Leão Cardoso da Silva, Pat G. Camp, Kerri A. Johannson, Michele R. Schaeffer, Pearce Wilcox, Jordan A. Guenette, Christopher J. Ryerson	2017	57
19	Frailty and postoperative outcomes in patients undergoing surgery for degenerative spine disease The Spine Journal ·Alana M. Flexman, Raphaële Charest-Morin, Nicholai A. Oostveen, John Street, Christopher J. Ryerson	2016	134
20	Unclassifiable interstitial lung disease: A review Respirology ·Kate Skolnik, Christopher J. Ryerson	2015	45

About Christopher J. Ryerson

Christopher J. Ryerson is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Pathology and Forensic Medicine, Geriatrics and Gerontology and Critical Care and Intensive Care Medicine, having authored 201 papers that have together received 8.5k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (160 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (58 papers), Sarcoidosis and Beryllium Toxicity Research (48 papers), Medical Imaging and Pathology Studies (33 papers), Systemic Sclerosis and Related Diseases (25 papers), Pulmonary Hypertension Research and Treatments (22 papers), Occupational and environmental lung diseases (20 papers) and Respiratory and Cough-Related Research (18 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (7.2k citations), Physiology (2.5k citations), Pathology and Forensic Medicine (1.1k citations), Geriatrics and Gerontology (163 citations) and Critical Care and Intensive Care Medicine (196 citations). Christopher J. Ryerson has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Harold R. Collard, Joyce Lee, Kirk D. Jones, Brett M. Elicker, Talmadge E. King, Brett Ley, Jay H. Ryu, Sabina A. Guler, Kerri A. Johannson and Alyson W. Wong. Their work appears in journals such as CHEST Journal, American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal, Annals of the American Thoracic Society and Respirology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact